Revvity's recent FDA clearance for its testosterone assay isn't just another regulatory checkbox—it's a glimpse into how this diagnostics player keeps expanding its testing portfolio. With the stock sitting 11% above its 200-day moving average and 51% implied volatility offering rich premium, selling the $90 put for $2.73 looks like smart positioning.
The trade math works beautifully here. At a $90 strike versus the current $101.22 price, we're betting RVTY stays above a level it hasn't seen since August. That's an 11% downside buffer with 589 days to expiration—plenty of time for the healthcare diagnostics thesis to play out. The $2.73 premium represents a 3.1% return on the $90 strike, annualizing to roughly 1.9%.
What makes RVTY compelling beyond the recent FDA news is its position in the diagnostics ecosystem. With an 8.3% profit margin and analyst targets pointing to $114, the company trades at reasonable multiples for a healthcare tech play. The 1.05 beta suggests it moves roughly in line with the broader market, avoiding the wild swings that make option selling treacherous.
The testosterone assay approval matters because it demonstrates RVTY's ability to systematically expand its automated testing solutions. Each FDA clearance doesn't just add a new product—it deepens the moat around their existing customer relationships. Labs don't switch testing platforms lightly.
With 49 days to expiration and the stock trading well above our strike, this put sale offers a solid risk-adjusted return in a sector that's seeing steady demand for diagnostic innovation.
Today's Atlas Trades
AFRM — Short Put
- Strike: $68.0
- Expiration: 2026-06-26
- Premium: $2.05
- Stock Price: $73.00
- IV: 53.2%
- Delta: -0.283
- DTE: 28
BTU — Short Put
- Strike: $27.0
- Expiration: 2026-06-26
- Premium: $0.8
- Stock Price: $29.10
- IV: 53.9%
- Delta: -0.276
- DTE: 28
TMO — Short Put
- Strike: $470.0
- Expiration: 2026-06-26
- Premium: $14.1
- Stock Price: $487.22
- IV: 42.0%
- Delta: -0.347
- DTE: 28
HGV — Short Put
- Strike: $50.0
- Expiration: 2026-06-18
- Premium: $1.49
- Stock Price: $51.98
- IV: 50.3%
- Delta: -0.342
- DTE: 20
PONY — Short Put
- Strike: $9.0
- Expiration: 2026-07-02
- Premium: $0.28
- Stock Price: $9.96
- IV: 57.1%
- Delta: -0.246
- DTE: 34
EVMN — Short Put
- Strike: $22.5
- Expiration: 2026-06-18
- Premium: $0.69
- Stock Price: $23.33
- IV: 50.2%
- Delta: -0.350
- DTE: 20
QLYS — Short Put
- Strike: $90.0
- Expiration: 2026-07-17
- Premium: $2.69
- Stock Price: $100.37
- IV: 48.9%
- Delta: -0.234
- DTE: 49
RVTY — Short Put
- Strike: $90.0
- Expiration: 2026-07-17
- Premium: $2.73
- Stock Price: $101.22
- IV: 51.0%
- Delta: -0.227
- DTE: 49
BLFS — Short Put
- Strike: $22.5
- Expiration: 2026-07-17
- Premium: $0.66
- Stock Price: $25.25
- IV: 49.6%
- Delta: -0.226
- DTE: 49
HEI — Short Put
- Strike: $310.0
- Expiration: 2026-07-17
- Premium: $9.34
- Stock Price: $345.07
- IV: 48.7%
- Delta: -0.236
- DTE: 49
FET — Short Put
- Strike: $45.0
- Expiration: 2026-07-17
- Premium: $1.33
- Stock Price: $50.78
- IV: 51.1%
- Delta: -0.222
- DTE: 49
TFX — Short Put
- Strike: $115.0
- Expiration: 2026-07-17
- Premium: $3.36
- Stock Price: $129.66
- IV: 50.6%
- Delta: -0.222
- DTE: 49